Imaging tumour hypoxia with Positron Emission Tomography

I N Fleming, R Manavaki, P J Blower, C West, K J Williams, A L Harris, J Domarkas, S Lord, C Baldry, F J Gilbert

Research output: Contribution to journalLiterature reviewpeer-review

220 Citations (Scopus)
8 Downloads (Pure)


Hypoxia, a hallmark of most solid tumours, is a negative prognostic factor due to its association with an aggressive tumour phenotype and therapeutic resistance. Given its prominent role in oncology, accurate detection of hypoxia is important, as it impacts on prognosis and could influence treatment planning. A variety of approaches have been explored over the years for detecting and monitoring changes in hypoxia in tumours, including biological markers and noninvasive imaging techniques. Positron emission tomography (PET) is the preferred method for imaging tumour hypoxia due to its high specificity and sensitivity to probe physiological processes in vivo, as well as the ability to provide information about intracellular oxygenation levels. This review provides an overview of imaging hypoxia with PET, with an emphasis on the advantages and limitations of the currently available hypoxia radiotracers.
Original languageEnglish
Pages (from-to)238-250
Number of pages13
JournalBritish Journal of Cancer
Issue number2
Early online date16 Dec 2014
Publication statusPublished - 20 Jan 2015


  • positron emission tomography (PET)
  • imaging
  • oncology
  • cancer
  • hypoxia
  • radiotracer


Dive into the research topics of 'Imaging tumour hypoxia with Positron Emission Tomography'. Together they form a unique fingerprint.

Cite this